1-(7-Amino-3,4-dihydroisoquinolin-2(1H)-YL)-2,2,2-trifluoroethanone → Trifluoroacetamide pyrazolopyridazine
反応式
ClC1N=C(C2C(C3C=C(NC(=O)C4C(F)=CC=CC=4F)C=CC=3)=[N:10][N:11]3C=CC=CC=23)C=CN=1.[F:34][C:35]([F:50])([F:49])[C:36]([N:38]1CCC2[C:40](=[CH:41][C:42]([NH2:48])=[CH:43]C=2)[CH2:39]1)=[O:37]>CC(O)C>[NH:10]1[C:41]2[CH:40]=[CH:39][N:38]=[N:48][C:42]=2[CH:43]=[N:11]1.[F:34][C:35]([F:50])([F:49])[C:36]([NH2:38])=[O:37]参加物
反応条件
- 温度
- 160 °C
実験手順
A mixture of N-{3-[3-(2-chloro-4-pyrimidinyl)pyrazolo[1,5-a]pyridin-2-yl]phenyl}-2,6-difluorobenzamide (200 mg, 0.43 mmol) and 2-(trifluoroacetyl)-1,2,3,4-tetrahydro-7-isoquinolinamine (211 mg, 0.86 mmol) in a few mL i-PrOH was heated in a microwave apparatus at 160° C. until the reaction was complete. The by partitioning the reaction mixture between saturated aqueous NaHCO3 and CHCl3. The organic layer was washed with brine, dried over Na2SO4, filtered and concentrated to give a residue that was purified by silica gel chromatography to afford the intermediate trifluoroacetamide pyrazolopyridazine (350 mg). A portion of this material (250 mg) was subjected to similar conditions as described in Example 62, step F to afford the title compound (198 mg) as a tan powder. LC-MS (AP)+=574.07. 1H NMR (400 MHz, DMSO-d6) δ 2.59 (t, 2H, J=5.5), 2.89 (t, 2H, J=5.5), 3.74 (s, 2H), 6.46 (d, 1H, J=5.1), 6.90 (d, 1H, J=8.2), 7.10 (t, 1H, J=6.7), 7.22 (d, 1H, J=8.0), 7.24 (d, 1H, J=7.9), 7.32 (s, 1H, 7.34 (s, 1H), 7.44-7.48 (m, 3H), 7.53-7.60 (m, 1H), 7.80 (d, 1H, J=8.0), 7.97 (s, 1H), 8.21 (d, 1H, J=5.3), 8.46 (d, 1H, J=9.1), 8.82 (d, 1H, J=6.7), 9.37 (s, 1H).
後処理
- customThe by partitioning the reaction mixture between saturated aqueous NaHCO3 and CHCl3
- washThe organic layer was washed with brine
- dry with materialdried over Na2SO4
- filtrationfiltered
- concentrationconcentrated
- customto give a residue that
- customwas purified by silica gel chromatography
出典と根拠
- ORDレコード
- ord-623f42e7bad04e7b8c8a46cd85a44a54
- 出典データセット
- uspto-grants-2010_10
- 特許番号
- US07812022B2
反応ノート
読み込み中…